Medico Intercontinental Limited last traded at ₹26.40 (2026-10-13). Over the past month the stock moved +5.6%, three months the stock moved +14.9%, year the stock moved -30.6%. Its closing range over 52 weeks is ₹21.59 – ₹41.23, with the latest close 36.0% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1914, Medico Intercontinental Ltd is engaged in trading of Pharmaceutical products[1]
Business Overview:[1][2] MIL (Formerly M/S. Intercontinental Leasing & Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital, etc.
In the latest quarter (Jun 2026), Medico Intercontinental Limited reported sales of ₹20.71 crore (-3.0%) and net profit of ₹-4.05 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 20.71 | -0.69 | -3.33 | -4.05 | -1.45 |
| Mar 2026 | 22.49 | 1.61 | 7.16 | -2.33 | -0.65 |
| Dec 2025 | 19.85 | 1.59 | 8.01 | -1.66 | -0.22 |
| Sep 2025 | 20.40 | -0.88 | -4.31 | -4.51 | -1.65 |
| Jun 2025 | 21.35 | 0.68 | 3.19 | -2.49 | -0.68 |
| Mar 2025 | 21.16 | 1.94 | 9.17 | 1.17 | 1.17 |
| Dec 2024 | 18.43 | 1.91 | 10.36 | 1.17 | 1.17 |
| Sep 2024 | 36.45 | 2.71 | 7.43 | 1.63 | 1.63 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +112.9% | +29.3% | +34.8% | +10.7% | -44.0% | +7.7% | +6.3% | -3.0% |
| Operating profit growth | +106.9% | +28.2% | +25.2% | -58.5% | -132.5% | -16.8% | -17.0% | -201.5% |
| Net profit growth | +87.4% | +14.7% | +12.5% | -330.6% | -376.7% | -241.9% | -299.1% | – |
| EPS growth | +87.4% | +14.7% | +12.5% | -163.0% | -201.2% | -118.8% | -155.6% | – |
| OPM % | 7.4% | 10.4% | 9.2% | 3.2% | -4.3% | 8.0% | 7.2% | -3.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Medico Intercontinental Limited reported sales of ₹84.00 crore (-12.5%) and net profit of ₹-11.00 crore (-317.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 84.00 | 3.00 | 4.00 | -11.00 | -3.20 |
| Mar 2025 | 96.02 | 8.42 | 8.77 | 5.06 | 5.06 |
| Mar 2024 | 71.33 | 5.83 | 8.17 | 3.95 | 3.95 |
| Mar 2023 | 76.23 | 5.26 | 6.90 | 3.61 | 3.61 |
| Mar 2022 | 74.26 | 5.01 | 6.75 | 3.10 | 9.54 |
| Mar 2021 | 69.74 | 4.77 | 6.84 | 2.58 | 7.94 |
| Mar 2020 | 81.93 | 4.36 | 5.32 | 2.36 | 7.26 |
| Mar 2019 | 9.95 | 0.66 | 6.63 | 0.74 | 2.28 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | +723.4% | -14.9% | +6.5% | +2.7% | -6.4% | +34.6% | -12.5% |
| Operating profit growth | – | +560.6% | +9.4% | +5.0% | +5.0% | +10.8% | +44.4% | -64.4% |
| Net profit growth | +2366.7% | +218.9% | +9.3% | +20.2% | +16.5% | +9.4% | +28.1% | -317.4% |
| EPS growth | +2433.3% | +218.4% | +9.4% | +20.2% | -62.2% | +9.4% | +28.1% | -163.2% |
| OPM % | 6.6% | 5.3% | 6.8% | 6.8% | 6.9% | 8.2% | 8.8% | 4.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Medico Intercontinental Limited.
Get Free AI Stock Analysis FREE →Medico Intercontinental Ltd Falls to 52-Week Low of Rs 20.61 as Sell-Off Deepens
Medico Intercontinental Limited shares were last quoted at ₹26.40 (-1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Medico Intercontinental Limited has a price-to-earnings (P/E) ratio of 11.61 and a price-to-book (P/B) ratio of 0.61. The industry P/E is 29.63.
The 52-week high of Medico Intercontinental Limited is ₹43.00 and the 52-week low is ₹20.61.
The market capitalisation of Medico Intercontinental Limited is about ₹26.00 crore.
In the latest quarter (Jun 2026), Medico Intercontinental Limited reported sales of ₹20.71 crore (-3.0%) and net profit of ₹-4.05 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Medico Intercontinental Limited has a 3-year ROE of 4.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 58.51% of Medico Intercontinental Limited.
Medico Intercontinental Limited belongs to the Engineering - Industrial Equipments sector.
All Engineering - Industrial Equipments stocks · Browse all stocks A–Z